Rubinstein Lab OSUCCC – James
Por um escritor misterioso
Descrição
The Rubinstein Lab is focused on developing immune-based strategies for the treatment of cancer and human disease.
Shared Resources OSUCCC – James
Dr. Raphael Pollock, MD – Columbus, OH
BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis. - Abstract - Europe PMC
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts, Journal for ImmunoTherapy of Cancer
Collaborators — The Paulos Laboratory
The James Cancer Network Team
t 2006
Leukemia Research
MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer
Leading U.S. Cancer Center Selects RayStation for Proton Planning
MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer
